Association of vancomycin trough levels, AUC and AUC/MIC ratios with clinical outcomes in patients with enterococcal bacteremia: a prospective cohort study
Abstract Background The optimal vancomycin pharmacokinetic/pharmacodynamic (PK/PD) targets for successful treatment of enterococcal infections remain controversial. To clarify these targets, this study investigated the association of the vancomycin area under the curve (AUC), the AUC/minimum inhibit...
Saved in:
| Main Authors: | Eda Kubra Sel, Berfu Tufan, Gundag Kupra Atagun, Vildan Avkan Oguz, Ozgen Alpay Ozbek, Mukaddes Gumustekin, Serife Reyhan Ucku, Ayse Gelal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-11400-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating AUC estimators across complex sampling designs: insights from COVID-19 patient data
by: Amaia Iparragirre, et al.
Published: (2025-08-01) -
Correlation analysis of pharmacokinetic parameters of docetaxel AUC and adverse reactions in breast cancer patients
by: Yongzhe Tang, et al.
Published: (2025-05-01) -
Navigating Vancomycin and Acute Kidney Injury: AUC- vs. Trough-Guided Monitoring in Initial and Steady-State Therapy
by: Astrid Marovič, et al.
Published: (2025-04-01) -
Rosemary Sayigh (Ed.), Yusif Sayigh Arab Economist, Palestinian Patriot, A fractured Life Story, AUC Press, Cairo, New York, 2015, 386 p.
by: Jihane Sfeir
Published: (2017-12-01) -
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India
by: Sneh Bhargave, et al.
Published: (2025-04-01)